Member Info for upupandawaybby

4.8 news leaked?
5 ask

19% up

Climbing

What does the CEO of Polar do the day before he is issued 145,000 shares

Spends £15 million on SNG shares, canny bleeder

https://www.investegate.co.uk/polar-capital-hldgs--polr-/rns/director-pdmr-shareholding/202007221210137830T/

interesting piece particularly at the bottom from Polar fund manager Gareth Powell

https://citywire.co.uk/wealth-manager/news/polar-duo-warn-on-overexuberance-in-covid-vaccine-stocks/a1382879

So this morning I have been on numerous stocks & share pages posting the following and looks like the herd have taken notice.
It did get quite a lot of engagement on all the pages I posted on. Thanks to members on here I stole info from but it's all to give us that little push and exposure we need just before RNS here's what I posted;

If you’re looking for a literal gold mine.
I posted about HUM when I bought in last month at 28p it’s just hit 52 week high of 36p
52p Canaccord value when at 26p (40% higher now) & gold @ $1725 ( 1860 now 10% up)
- Does not include any value for the transformative Kouroussa acquisition.
- Does not include any value for the Dugbe project.
- Does not include any value for exploration success at Yanfolila.
“a year of life extension to Yanfolila would potentially add up to 10p/share”
“According to our estimates, for each US$100/oz change in the gold price, 2021E EBITDA would change by ~US$12m.”
Q2 production RNS due within 2 weeks – Gold expected to hit all time highs of $2000 next quarter
Here’s your research done for you.
https://canaccordgenuity.bluematrix.com/sellside/EmailDocViewer?encrypt=02566aef-a606-44aa-bc0a-5502d81c4c7b&mime=pdf&co=Canaccordgenuity&id=CA-InternalResearchDistribution@canaccordgenuity.com&source=mail
Also one of only 10 with score of 88
https://www.ii.co.uk/analysis-commentary/10-speculative-mining-stocks-gold-bugs-ii512214?utm_source=IBMW&utm_medium=email&utm_campaign=ii_Afternoon_round_up_newsletter_010720&utm_content=&spMailingID=9824796&spUserID=MTIxNjc3MzUzNTc5S0&spJobID=1550127733&spReportId=MTU1MDEyNzczMwS2

Waiting to see how long it takes before people click on to the polar CEO part that was released as an RNS 30 minutes ago lol

bargain and more than achievable

We are the only therapeutic in the world that has been granted trials for home use, patents worldwide for the most effective way of delivery of interferon b, inhaled direct to infected area,
We have been fast tracked as urgent public health study due to the evidence supporting the drug by NIHR, expedited approval from BOTH MHRA & HRA, The World Health Organization (WHO) identified us as a potential therapeutic as the ONLY phase 2/3 in the world via inhalation
We are now on multiple platforms in America as of yesterday also been added to more German ones, Matt Hanballs mentioned us in house of commons and Polar (a massive £15B ii) paid a premium for their shares buying 7% of the company after we spiked on Monday.
(Coincides nicely with Polar CEO Gavin Rochussen being issued a further 145,000 shares in Polar today that he can’t sell until July 2022)

What next, FDA approval, peer review, EMA, COPD results, home trial results, partnership/takeover news

This is the best and biggest opportunity of most of our lives, For this reason I am staying until our shares are froze, and we get bought for minimum £2 billion netting me a lovely £13.50 a share why not £5B netting £33.50 a share

Bringing some potential new PI up to speed

SNG001 is a viral treatment (Interferon-b A naturally occurring protein our body produces) for sars mers asthma copd future strains and mutations and they own the delivery method patents in UK europe US and Asia. This literally is the holy grail and is just a puff once a day on a nebuliser no hospital no injections absolute worldwide game changer.

Nip to Boots and buy one soon?

Couple of questions i've been asked
Does it matter only 100 patients in trial? Not really as IFN-b has been used for years and is a naturally occurring protein in our bodies not some mad scientist concocted drug. The trial was gold standard double blind placebo, this particular trial had 100 people but it's been used and tested on humans for 15 years

Out of interest what would stop another pharma making the same product.?
Plenty of pharmas already use IFN-b, the huge difference is they can only administer it through IV due to the fact that SNG owns the worldwide patent since 2009 of the delivery method of IFN-b virally. What it means is we already know interferons work and already have a benefit but through IV it's a far higher dose, more costly, less effective, more side effects, takes longer to get to the infected area (lungs) less gets there and so on. SNG protected method is no injections 100% delivery direct into lungs immediately.

What about a vaccine? Done this to death A lot of people that have just invested as it's big news may not be aware of how significant this is, a vaccine takes years to develop and are for a particular strain. By the time one has been developed for covid-19 it will have mutated into covid 22 for example and be useless NVM vaccine is a poisonous word and a man made concoction. SNG have the viral treatment (A naturally occuring protein our body produces) for sars mers asthma copd future strains and mutations and they own the patents in UK europe us and Asia. This literally is the holy grail and is just a puff once a day on a nebuliser no hospital no injections absolute worldwide game changer

How far will it go? 150 million shares in issue at mcap of £500M gives us £3.60 per share, however I feel there is no chance of Richard & co dedicating 15 years of their life and have the golden ticket and not getting their just rewards.

When you have every major pharma in the world bidding for the only company to currently have what looks like the answer and that answer will bring in £3-5 billion every flu season BEFORE you even look at what COPD brings in you start to see how ridiculous a £3.60 Finncap target really is

Based on cost and demand coupled with the fact a big pharma can buy us or miss out they can't then go and buy something else I see absolutely no reason why we wouldn't fetch at least £2 billion giving us roughly again £13.50 a share now £5 billion would be £33.50 a share, too optimistic? Maybe but don't rule it out and certainly my target of £2B I think is absolute barg

* With PUNIT lol

Look at NCYT they were first to market and nailed it even though their test is inferior to just about all the others but it's them that secured the orders.

We will be first to market but with a blinding product, backed up by the sp since close Monday.

How many shares can you name that shoot 500% in a day then 2 days later still held, look at MTPH 300% up and now 35% down.
If we don't get at least a £2b mcap as bare minimum i'll go for a pint for PUNIT

Price movement
https://www.investegate.co.uk/physiomics-plc--pyc-/rns/share-price-movement/202007221145047779T/

Volume by 11:30 someones filling their boots expecting another TR-1 would be nice to see if before close next time though

Grimshady - Sales & Marketing

I was very close to investing took too long to make a decision and the RNS dropped and you shot up

I don't think many pi that have sold out of SNG and won't be doing anytime soon.

Yes we do have the gold standard, yes the best test but I still stand by my previous comments our S&M is utter garbage

it doesn't say I clicked link and it said "Gold shoots to all-time high on weaker dollar & flight to safe havens.

Just had a news notification from marketwatch Gold hit all time high

tweet all news outlets, peston etc trump might spell our name wrong and shares of singgen go through the roof

Excellent find we should be helping spread this link